Epithalon is a synthetic tetrapeptide — Ala-Glu-Asp-Gly — derived from epithalamin, a natural polypeptide extract of the pineal gland. Developed by Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology, it is one of the most studied peptides in telomere biology and longevity research, with its proposed ability to activate telomerase in somatic cells generating significant scientific interest.
This item is not currently in stock. Message us on Telegram to check availability or place a request.
Join TelegramTelomeres — the protective caps at the ends of chromosomes — progressively shorten with each cell division, and their length is a key biomarker of cellular biological aging. Telomerase is the ribonucleoprotein enzyme that can reverse telomere shortening by adding DNA repeats to chromosome ends. In most somatic cells, telomerase activity is minimal or absent — active primarily in stem cells, germ cells, and select immune cells.
Khavinson and colleagues have published extensive work claiming that Epithalon activates telomerase in human somatic cells and extends telomere length. A 2020 Molecules paper reported that the AEDG peptide stimulates gene expression and protein synthesis during neurogenesis, proposing an epigenetic mechanism involving histone modification and gene regulatory elements as the underlying process.
The pineal gland context is relevant: epithalamin — the natural source material — is associated with melatonin regulation, circadian rhythm control, and immune-neuroendocrine coordination. Epithalon has been studied for effects on melatonin production in aged animals, with restorative effects on circadian melatonin amplitude reported in preclinical models.
Epithalon's proposed epigenetic mechanism centres on its ability to interact with chromatin structure and modify histone-DNA interactions, activating transcriptional programmes that may not be accessible in senescent somatic cells. This has been studied in the context of neurogenesis, where AEDG peptide treatment was associated with increased expression of neurogenesis-related genes and protein synthesis.
Research from Khavinson's group also documents Epithalon's effects on DNA methylation patterns in aged animal models, showing methylation pattern shifts in treated groups compared to untreated aged controls — though these findings are preliminary and require independent replication.
The pineal gland produces melatonin — the primary circadian timing hormone — and melatonin production declines substantially with age, a pattern observed in parallel with age-associated changes in circadian rhythm markers. Epithalon's derivation from pineal epithalamin has led to its use as a research compound in melatonin pathway studies.
Animal studies have reported differences in melatonin amplitude measurements in Epithalon-treated aged subject groups, with downstream markers in immune signalling, oxidative stress assays, and circadian rhythm parameters also studied. The circadian-immune signalling intersection is an active area of preclinical research in which Epithalon is used as a research compound.